GINKGO BIOWORKS HOLDINGS INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of Directors: Christian Henry

GINKGO BIOWORKS HOLDINGS INC.’s own tally for this item (“Elect Director: Christian Henry”): 99,921,002 for, 8,298,700 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the seven nominees…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 24 managers: 479,659 for, 138,835 against.

Institutional-manager reports, all 2 managers: 3 for, 2,000,000 against.

Description as filed by funds: Election of Directors: Harry E. Sloan

GINKGO BIOWORKS HOLDINGS INC.’s own tally for this item (“Elect Director: Harry E. Sloan”): 97,606,927 for, 11,209,651 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the seven nominees…”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 24 managers: 272,843 for, 345,651 against.

Institutional-manager reports, all 2 managers: 2,000,003 for.

Description as filed by funds: Election of Directors: Ross Fubini

GINKGO BIOWORKS HOLDINGS INC.’s own tally for this item (“Elect Director: Ross Fubini”): 106,213,906 for, 2,606,700 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the seven nominees…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 24 managers: 618,494 for.

Institutional-manager reports, all 2 managers: 2,000,003 for.

Description as filed by funds: Election of Directors: Shyam Sankar

GINKGO BIOWORKS HOLDINGS INC.’s own tally for this item (“Elect Director: Shyam Sankar”): 97,213,644 for, 11,609,182 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the seven nominees…”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 24 managers: 239,651 for, 378,843 against.

Institutional-manager reports, all 2 managers: 2,000,003 for.

Description as filed by funds: Election of Directors: Sri Kosuri

GINKGO BIOWORKS HOLDINGS INC.’s own tally for this item (“Elect Director: Sri Kosuri”): 106,050,270 for, 2,770,383 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the seven nominees…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 24 managers: 614,979 for, 3,515 against.

Institutional-manager reports, all 2 managers: 3 for, 2,000,000 against.

Description as filed by funds: TO APPROVE THE COMPANY'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, WHICH HAS BEEN UPDATED TO, AMONG OTHER THINGS, REMOVE PROVISIONS RELATED TO OUR MERGER WITH SOARING EAGLE ACQUISITION CORP. AND OUR DOMESTICATION PROCESS, WHICH ARE NO LONGER RELEVANT TO OUR BUSINESS.

GINKGO BIOWORKS HOLDINGS INC.’s own tally for this item (“3. Charter Updates Proposal Item 3 was to approve the Company's Amended and Restated Certificate of Incorporation, which has been updated to, among other things, remove provisions related to its merger with Soaring Eagle”): 4,472,896,115 for, 19,004,772 against — passed, per its Form 8-K filed August 15, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Pursuant to the foregoing vote, the Charter Updates Proposal was approved.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 43 managers: 49,955,452 for. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 3 managers: 8,050,100 for.

Description as filed by funds: TO APPROVE ARTICLE VIII OF THE COMPANY'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO PERMIT OFFICER EXCULPATION.

The 44 asset managers below reported 35,529,466 for, 14,457,086 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: To approve Article V, Section 1(c) of the Company's Amended and Restated Charter to effect, at the discretion of the Board, a reverse stock split of the issued & outstanding shares of Class A and Class B common stock, which would combine a whole number of outstanding shares of the Class A and Class B common stock in a range of not less than one-for- twenty shares and not more than one-for-forty shares into one share of Class A common stock or Class B common stock, as applicable, and reduce the number of outstanding shares of Class A and Class B common stock.

GINKGO BIOWORKS HOLDINGS INC.’s own tally for this item (“Pursuant to the foregoing vote, the Reverse Stock Split Proposal was approved. 2.”): 4,043,285,631 for, 377,594,737 against — passed, per its Form 8-K filed August 15, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Pursuant to the foregoing vote, the Officer Exculpation Proposal was approved.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 22 asset managers below reported 16,477,133 for.

Description as filed by funds: To approve Article V, Section 1(c) of the Company's Amended and Restated Certificate of Incorporation to effect, at the discretion of the Company's Board of Directors, a reverse stock split of the issued and outstanding shares of Class A common stock and Class B common stock, which would combine a whole number of outstanding shares of the Class A common stock and Class B common stock in a range of not less than one-for-twenty (1:20) shares and not more than one-for-forty (1:40) shares into one share of Class A common stock or Class B common stock, as applicable, and reduce the number of outstanding shares of Class A common stock and Class B common stock.

GINKGO BIOWORKS HOLDINGS INC.’s own tally for this item (“Pursuant to the foregoing vote, the Reverse Stock Split Proposal was approved. 2.”): 4,043,285,631 for, 377,594,737 against — passed, per its Form 8-K filed August 15, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Pursuant to the foregoing vote, the Officer Exculpation Proposal was approved.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 23 asset managers below reported 33,509,419 for.

Description as filed by funds: Advisory vote to approve executive compensation.

GINKGO BIOWORKS HOLDINGS INC.’s own tally for this item (“3. Advisory vote to approve executive compensation Proposal three was an advisory vote to approve the compensation of the Company's named executive officers, designated to be voted upon by the holders of Class A common s”): 107,192,721 for, 847,055 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Pursuant to the foregoing vote, the compensation of the Company's named executive officers was approved on an advisory basis.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 24 managers: 614,979 for, 3,515 against.

Institutional-manager reports, all 163 managers: 20,776,865 for, 1,350 against, 775,568 abstained. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

GINKGO BIOWORKS HOLDINGS INC.’s own tally for this item (“2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm Proposal two was the ratification of the appointment of Deloitte & Touche LLP as the Company's in”): 118,198,250 for, 210,341 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Pursuant to the foregoing vote, the ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was approved.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 24 managers: 618,494 for.

Institutional-manager reports, all 3 managers: 2,000,103 for.